Bio-Techne Highlights Progress on Climate, Innovation, and Culture in 2025 Sustainability ReportPRNewsWire • 09/24/25
Bio-Techne Corporation (TECH) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptSeeking Alpha • 09/10/25
Bio-Techne Corporation (TECH) Presents At Baird Global Healthcare Conference 2025 TranscriptSeeking Alpha • 09/09/25
ScaleReady Awards G-Rex® Grants to Support Cell and Gene Therapy Manufacturing in CaliforniaPRNewsWire • 09/09/25
Bio-Techne Corporation (TECH) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 TranscriptSeeking Alpha • 09/03/25
ScaleReady Announces Award of a G-Rex® Grant to the Gates Institute's Translational Sciences LaboratoryPRNewsWire • 08/14/25
Bio-Techne Q4 Earnings Beat Estimates, Gross Margin Down, Stock FallsZacks Investment Research • 08/06/25
10 stocks favored to gain up to 30% in a sector that has missed this year's rallyMarket Watch • 07/31/25
ScaleReady announces multiple G-Rex® Grants have been awarded to investigators at University of Minnesota's Center for Genome EngineeringPRNewsWire • 07/31/25
Bio-Techne to Host Conference Call on August 6, 2025, to Announce Fourth Quarter and Fiscal 2025 Financial ResultsPRNewsWire • 07/17/25
Spear Bio Announces Strategic Partnership with Bio-Techne to Accelerate the Deployment of Its Next-Generation Immunoassay TechnologyBusiness Wire • 07/15/25
Bio-Techne and Spear Bio Announce Strategic Partnership to Advance Therapeutic Development with Ultrasensitive Biomarker DetectionPRNewsWire • 07/15/25
Bio-Techne's Simple Western™ Technology Utilized in Recent FDA Approval of ZEVASKYN™ Cell-Based Gene TherapyPRNewsWire • 07/14/25
Bio-Techne's New USP Deal on mAb and Gene Therapy May Boost Its StockZacks Investment Research • 06/30/25
Bio-Techne and USP Announce Collaboration to Accelerate Monoclonal Antibody and Gene Therapy Product DevelopmentPRNewsWire • 06/24/25